¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : Á¦Ç° À¯Çüº°, ¼ö¸éÀå¾Öº°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷º° ¿¹Ãø(2024-2031³â)
Sleep Aids Market Size, Share, Growth Analysis, By Product Type (Mattresses & Pillows, Medications), By Sleep Disorder (Insomnia, Sleep Apnea), By Distribution Channel, By End-User, By Region - Industry Forecast 2024-2031
¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 780¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£(2024-2031³â)ÀÇ CAGRÀº 5.4%·Î, 2023³â 822¾ï 1,000¸¸ ´Þ·¯¿¡¼ 2031³â¿¡´Â 1,252¾ï 2,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
¼ö¸éÀå¾Ö´Â ÀÏ»ó ±â´É¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í, ³· µ¿¾È °úµµÇÑ Á¹À½À» À¯¹ßÇÏ¿© Çо÷ ¹× Á÷¾÷ ȯ°æ, Á¤½Å°Ç°, ´ëÀÎ °ü°è, ½ÉÀ庴 ¹× ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ À§Çè°ú °°Àº ¹®Á¦¸¦ ¾ÇȽÃŵ´Ï´Ù. ÈçÇÑ ÁúȯÀ¸·Î´Â ºÒ¸éÁõ, ¼ö¸é¹«È£ÈíÁõ, ÇÏÁöºÒ¾ÈÁõÈıº, ±â¸éÁõ µîÀÌ ÀÖ½À´Ï´Ù. Ä¡·á ¿É¼ÇÀº ÇÇÆ®¸®»êÆ®, ¸ð´ÙÇÇ´Ò, ¾Ë¸ð´ÙÇÇ´Ò°ú °°Àº ÀǾàǰºÎÅÍ ¸á¶óÅä´Ñ, ÀÚ·¹ÇÁ·Ð°ú °°Àº Ä¡·áÁ¦¿Í ½ÃÁß¿¡¼ ÆÇ¸ÅµÇ´Â º¸ÃæÁ¦±îÁö ´Ù¾çÇÕ´Ï´Ù. ¿îµ¿À̳ª ȯ°æ Á¶Àý°ú °°Àº »ýȰ½À°ü Á¶ÀýÀº ¼ö¸éÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖÁö¸¸, ¾à¹°ÀÇ ÀáÀçÀûÀÎ ºÎÀÛ¿ë°ú ³ôÀº ȯÀÚ ºÒº¹Á¾·üÀº ¼ö¸é º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖÀ¸¸ç, 2024³â±îÁö ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀº ¼ö¸é °Ç° ÁõÁøÀ» ¸ñÇ¥·Î ÇÏ´Â ½ÃÀå ÀÌÇØ°ü°èÀÚ ¹× ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
¸ñÂ÷
¼·Ð
- Á¶»çÀÇ ¸ñÀû
- Á¶»ç ¹üÀ§
- Á¤ÀÇ
Á¶»ç ¹æ¹ý
- Á¤º¸ Á¶´Þ
- 2Â÷ µ¥ÀÌÅÍ¿Í 1Â÷ µ¥ÀÌÅÍ ¹æ¹ý
- ½ÃÀå ±Ô¸ð ¿¹Ãø
- ½ÃÀåÀÇ ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ
°³¿ä
- ¼¼°è ½ÃÀå Àü¸Á
- °ø±Þ°ú ¼ö¿äÀÇ µ¿Ç⠺м®
- ºÎ¹®º° ±âȸ ºÐ¼®
½ÃÀå ¿ªÇаú Àü¸Á
- ½ÃÀå °³¿ä
- ½ÃÀå ±Ô¸ð
- ½ÃÀå ¿ªÇÐ
- ÃËÁø¿äÀΰú ±âȸ
- ¾ïÁ¦¿äÀΰú °úÁ¦
- PorterÀÇ »ê¾÷ ºÐ¼®
ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®
- ÁÖ¿ä ¼º°ø ¿äÀÎ
- °æÀïÀÇ Á¤µµ
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ½ÃÀå ¿¡ÄڽýºÅÛ
- ½ÃÀåÀÇ ¸Å·Â Áö¼ö(2023³â)
- PESTEL ºÐ¼®
- °Å½Ã°æÁ¦ ÁöÇ¥
- ¹ë·ùüÀÎ ºÐ¼®
- °¡°Ý ºÐ¼®
- ±ÔÁ¦ »óȲ
- ƯÇ㠺м®
- »ç·Ê ¿¬±¸
- °í°´°ú ±¸¸Å ±âÁØ ºÐ¼®
¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð : Á¦Ç° À¯Çüº°
- ½ÃÀå °³¿ä
- ¸ÅÆ®¸®½º¿Í º£°³
- ÀǾàǰ
- ó¹æ¿¡ ±â¹Ý
- OTC(Over-The-Counter )
- ¼ö¸é¹«È£ÈíÁõ¿ë ±â±â
- ±âµµ¾ç¾Ð(PAP) ±â±â
- ASV(Adaptive Servo-Ventilation) ±â±â
- ±¸° ±â±â
- ¸¶½ºÅ©¿Í ¾×¼¼¼¸®
- ¼ö¸é ¿¬±¸¼Ò
- ±âŸ Á¦Ç°
- ¼ö¸é ÃßÀû µð¹ÙÀ̽º
- ÈÀÌÆ® ³ëÀÌÁî ¸Ó½Å
¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð : ¼ö¸éÀå¾Öº°
- ½ÃÀå °³¿ä
- ºÒ¸éÁõ
- ¼ö¸é¹«È£ÈíÁõ
- ÇÏÁöºÒ¾ÈÁõÈıº
- ±â¸éÁõ
- ¸ùÀ¯º´
- ±âŸ ¼ö¸éÀå¾Ö
¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð : À¯Åë ä³Îº°
- ½ÃÀå °³¿ä
- ¼Ò¸Å ¾à±¹
- º´¿ø ¾à±¹
- ¿Â¶óÀÎ ¾à±¹
- ¼ö¸é Ŭ¸®´Ð
- ±âŸ
¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð : ÃÖÁ¾»ç¿ëÀÚº°
- ½ÃÀå °³¿ä
- ¼ºÀÎ
- ¾î¸°ÀÌ
- °í·ÉÀÚ
¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð : Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´ Áö¿ª
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« Áö¿ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- GCC ±¹°¡
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°æÀï Á¤º¸
- »óÀ§ 5»çÀÇ ºñ±³
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
- ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
- ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ
- ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
- ÁÖ¿ä ±â¾÷ÀÇ ±â¾÷ °³¿ä
- ȸ»ç °³¿ä
- Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
- ºÎ¹®º° Á¡À¯À² ºÐ¼®
- ¸ÅÃâÀÇ Àü³â´ëºñ ºñ±³(2021-2023)
ÁÖ¿ä ±â¾÷ °³¿ä
- Merck & Co., Inc.(USA)
- Sanofi(France)
- Koninklijke Philips N.V.(Netherlands)
- Pfizer Inc.(USA)
- GlaxoSmithKline PLC(UK)
- SleepMed Inc.(USA)
- Cadwell Laboratories Inc.(USA)
- Natus Medical Incorporated(USA)
- Fisher & Paykel Healthcare(New Zealand)
- ResMed Inc.(USA)
- Teva Pharmaceutical Industries Ltd.(Israel)
- AstraZeneca(UK)
- Takeda Pharmaceutical Company Limited(Japan)
- Vanda Pharmaceuticals Inc.(USA)
- Mylan N.V.(USA)
- Koninklijke Philips N.V.(Netherlands)
°á·Ð°ú ±ÇÀå»çÇ×
KSA
Global Sleep Aids Market size was valued at USD 78.0 billion in 2022 and is poised to grow from USD 82.21 billion in 2023 to USD 125.22 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).
Sleep disorders significantly affect daily functioning, contributing to excessive daytime sleepiness and exacerbating challenges in academic and professional settings, mental well-being, interpersonal relationships, and the risk of chronic conditions like heart disease and diabetes. Common disorders include insomnia, sleep apnea, restless legs syndrome, and narcolepsy. Treatment options range from pharmaceutical solutions such as pitolisant, modafinil, and armodafinil to therapies and over-the-counter supplements like melatonin and zaleplon. While lifestyle adjustments like exercise and environmental control can enhance sleep quality, potential side effects of medications and high rates of patient non-adherence may hinder growth in the sleep aids market. As we approach 2024, addressing these challenges will be crucial for market stakeholders and healthcare providers aiming to improve sleep health.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Sleep Aids Market Segmental Analysis
Global Sleep Aids Market is segmented by product type, sleep disorder, distribution channel, end-user and region. Based on product type, the market is segmented into mattresses & pillows, medications, sleep apnea devices, sleep laboratories and other products. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking and other sleep disorders. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, sleep clinics and others. Based on end-user, the market is segmented into adults, children and elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Sleep Aids Market
The primary impetus behind the expansion of the global sleep aids market is the evolving sleep patterns among people, driven by contemporary lifestyles. As individuals grapple with increased stress, demanding work schedules, and technology-induced sleep disruption, the need for effective sleep solutions has surged. Additionally, rising disposable incomes and enhanced healthcare access are likely to further fuel the demand for sleep aids over the coming years. This convergence of factors-modern living challenges and heightened health consciousness-positions the sleep aids market for robust growth in the foreseeable future, as consumers seek out products that promote better sleep quality and overall well-being.
Restraints in the Global Sleep Aids Market
The Global Sleep Aids market faces significant challenges due to the rising complexity of treating sleep disorders driven by advanced technological innovations. Moreover, the absence of adequate regulatory documentation for the prescription and utilization of sleep medications, coupled with improper settings on sleep devices, hampers effective treatment options. These issues contribute to a stagnation in market growth, as consumers and healthcare providers grapple with the limitations of current solutions. As a result, the potential for expansion in the sleep aids market is stifled, hindering advancements in product development and overall accessibility to effective treatment alternatives for individuals experiencing sleep disturbances.
Market Trends of the Global Sleep Aids Market
The Global Sleep Aids market is experiencing significant growth, driven by rising consumer awareness of sleep-related disorders and the increasing prevalence of issues such as restless leg syndrome and narcolepsy. Innovative products like sleep-inducing pillows and mattresses are gaining traction among health-conscious consumers seeking better sleep quality. The burgeoning demand for both pharmaceutical and non-pharmaceutical sleep solutions reflects a broader trend towards holistic wellness. As people continue to prioritize sleep as a critical factor in overall health, the market is poised for further expansion, generating substantial revenue opportunities for manufacturers and suppliers within the sleep aids sector.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2023
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Landscape
- Patent Analysis
- Case Studies
- Customer & Buying Criteria Analysis
Global Sleep Aids Market Size by Product Type & CAGR (2024-2031)
- Market Overview
- Mattresses & Pillows
- Medications
- Prescription-Based
- Over-The-Counter (OTC)
- Sleep Apnea Devices
- Positive Airway Pressure (PAP) Devices
- Adaptive Servo-Ventilation (ASV) Devices
- Oral Appliances
- Masks & Accessories
- Sleep Laboratories
- Other Products
- Sleep Tracking Devices
- White Noise Machines
Global Sleep Aids Market Size by Sleep Disorder & CAGR (2024-2031)
- Market Overview
- Insomnia
- Sleep Apnea
- Restless Legs Syndrome
- Narcolepsy
- Sleep Walking
- Other Sleep Disorders
Global Sleep Aids Market Size by Distribution Channel & CAGR (2024-2031)
- Market Overview
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Sleep Clinics
- Others
Global Sleep Aids Market Size by End-User & CAGR (2024-2031)
- Market Overview
- Adults
- Children
- Elderly
Global Sleep Aids Market Size & CAGR (2024-2031)
- North America (Product Type, Sleep Disorder, Distribution Channel, End-User)
- Europe (Product Type, Sleep Disorder, Distribution Channel, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Sleep Disorder, Distribution Channel, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Sleep Disorder, Distribution Channel, End-User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Sleep Disorder, Distribution Channel, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2023
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
- Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SleepMed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cadwell Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fisher & Paykel Healthcare (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ResMed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vanda Pharmaceuticals Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations